Familial factors and genetic predisposition to cancer

population studies.

Henry T. Lynch, J. F. Lynch

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

Hereditary cancer-prone families provide one of the most powerful and potentially cost-effective models for cancer prevention and control. The public health impact of this problem is enormous when considering that between 5 to 10% of the total cancer burden is hereditary. At least 200 well-defined hereditary cancer syndromes have been identified. In spite of its impact, attention to family history of cancer is often given short shrift and, consequently, clinical expertise in identifying hereditary forms of cancer is exceedingly limited. This may change as a result of recent advances in biomolecular genetics which, predictably, may lead to the cloning of many of these deleterious genes so that diagnostic and even pharmacologic and preventive potential may be achieved. We focus attention on advances which have been made in the recognition of hereditary forms of carcinoma of the breast and colon. Emphasis is given to biomarker research and the recognition of the distinctive natural history of these hereditary cancer syndromes. This will then enable surveillance and management strategies to be more effectively targeted.

Original languageEnglish
Pages (from-to)49-57
Number of pages9
JournalCancer Detection and Prevention
Volume15
Issue number1
StatePublished - 1991

Fingerprint

Genetic Predisposition to Disease
Hereditary Neoplastic Syndromes
Population
Neoplasms
Organism Cloning
Colon
Public Health
Biomarkers
Breast Neoplasms
Costs and Cost Analysis
Research
Genes

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Oncology

Cite this

Familial factors and genetic predisposition to cancer : population studies. / Lynch, Henry T.; Lynch, J. F.

In: Cancer Detection and Prevention, Vol. 15, No. 1, 1991, p. 49-57.

Research output: Contribution to journalReview article

@article{a0ff7dd536874c2aaafe0964302a7efa,
title = "Familial factors and genetic predisposition to cancer: population studies.",
abstract = "Hereditary cancer-prone families provide one of the most powerful and potentially cost-effective models for cancer prevention and control. The public health impact of this problem is enormous when considering that between 5 to 10{\%} of the total cancer burden is hereditary. At least 200 well-defined hereditary cancer syndromes have been identified. In spite of its impact, attention to family history of cancer is often given short shrift and, consequently, clinical expertise in identifying hereditary forms of cancer is exceedingly limited. This may change as a result of recent advances in biomolecular genetics which, predictably, may lead to the cloning of many of these deleterious genes so that diagnostic and even pharmacologic and preventive potential may be achieved. We focus attention on advances which have been made in the recognition of hereditary forms of carcinoma of the breast and colon. Emphasis is given to biomarker research and the recognition of the distinctive natural history of these hereditary cancer syndromes. This will then enable surveillance and management strategies to be more effectively targeted.",
author = "Lynch, {Henry T.} and Lynch, {J. F.}",
year = "1991",
language = "English",
volume = "15",
pages = "49--57",
journal = "Cancer Epidemiology",
issn = "1877-7821",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Familial factors and genetic predisposition to cancer

T2 - population studies.

AU - Lynch, Henry T.

AU - Lynch, J. F.

PY - 1991

Y1 - 1991

N2 - Hereditary cancer-prone families provide one of the most powerful and potentially cost-effective models for cancer prevention and control. The public health impact of this problem is enormous when considering that between 5 to 10% of the total cancer burden is hereditary. At least 200 well-defined hereditary cancer syndromes have been identified. In spite of its impact, attention to family history of cancer is often given short shrift and, consequently, clinical expertise in identifying hereditary forms of cancer is exceedingly limited. This may change as a result of recent advances in biomolecular genetics which, predictably, may lead to the cloning of many of these deleterious genes so that diagnostic and even pharmacologic and preventive potential may be achieved. We focus attention on advances which have been made in the recognition of hereditary forms of carcinoma of the breast and colon. Emphasis is given to biomarker research and the recognition of the distinctive natural history of these hereditary cancer syndromes. This will then enable surveillance and management strategies to be more effectively targeted.

AB - Hereditary cancer-prone families provide one of the most powerful and potentially cost-effective models for cancer prevention and control. The public health impact of this problem is enormous when considering that between 5 to 10% of the total cancer burden is hereditary. At least 200 well-defined hereditary cancer syndromes have been identified. In spite of its impact, attention to family history of cancer is often given short shrift and, consequently, clinical expertise in identifying hereditary forms of cancer is exceedingly limited. This may change as a result of recent advances in biomolecular genetics which, predictably, may lead to the cloning of many of these deleterious genes so that diagnostic and even pharmacologic and preventive potential may be achieved. We focus attention on advances which have been made in the recognition of hereditary forms of carcinoma of the breast and colon. Emphasis is given to biomarker research and the recognition of the distinctive natural history of these hereditary cancer syndromes. This will then enable surveillance and management strategies to be more effectively targeted.

UR - http://www.scopus.com/inward/record.url?scp=0026041335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026041335&partnerID=8YFLogxK

M3 - Review article

VL - 15

SP - 49

EP - 57

JO - Cancer Epidemiology

JF - Cancer Epidemiology

SN - 1877-7821

IS - 1

ER -